Porcine Vaccine Market 2028 By Technology, Disease Indication, End User | The Insight Partners

Porcine Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines); Disease Indication (Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Others); End User (Veterinary Hospitals, Hog/Pig Production Farm)

Report Code: TIPRE00021695 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Infection of swine with porcine parvovirus (PPV) is reported across the world, which may be resulted into reproductive failure in swine or cutaneous lesions in piglets. The first vaccine to aid in the prevention of the porcine reproductive and respiratory syndrome (PRRS) was approved for use in Spain in 1994, since then a number of additional vaccines (comprising either attenuated or inactivated PRRSV) have been developed in the U.S. and Europe. These vaccines include a different strain of the virus of either the North American or European genotype. According to an article published in NCBI, in 2020, around 70% of pig producers are small farmers with farms fewer than 50 pigs each, and hygienic measures and feed of the pigs is not controlled, which has raised demand for porcine vaccines market.

MARKET DYNAMICS

Porcine vaccine market is driving due to factors such as increasing incidences of zoonotic diseases, increasing number of biotechnology companies, research institutes engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector. However, the high cost of maintaining, handling, and storage of vaccines is likely to create a negative impact on the growth of this market.

MARKET SCOPE

The Porcine vaccine market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Porcine vaccine Market with detailed market segmentation by technology, disease indication and end user. The Porcine vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Porcine vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Porcine vaccine market is segmented based on technology, disease indication and end user. Based on technology, market is segmented as inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, DNA vaccines. Based on disease indication, market is segmented as diarrhea, swine influenza, arthritis, Bordetella rhinitis, porcine reproductive and respiratory virus (PRRSV), porcine circovirus associated disease (PCVAD), others. Based on end user, market is segmented as veterinary hospitals, hog/pig production farm.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Porcine vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Porcine vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Porcine vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Porcine vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Porcine vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Porcine vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Porcine vaccine in the global market. Below mentioned is the list of few companies engaged in the Porcine vaccine Market.

The report also includes the profiles of key players in Porcine vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Bayer AG
  •   Bimeda Animal Health
  •   Boehringer Ingelheim GmbH
  •   Ceva Sante Animale
  •   Eli Lilly and Company
  •   Merck and Co., Inc.
  •   Sanofi S.A
  •   Vetoquinol
  •   Zoetis, Inc.
  •   Hipra
  •   Elanco
  •   Formosa Biomedical Inc.
  •   Shoken Pharmaceutical Co., Ltd
  •   MSD Animal Health

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Porcine Vaccine Market - By Technology
1.3.2 Porcine Vaccine Market - By Disease Indication
1.3.3 Porcine Vaccine Market - By End User
1.3.4 Porcine Vaccine Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PORCINE VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PORCINE VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PORCINE VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PORCINE VACCINE - GLOBAL MARKET OVERVIEW
6.2. PORCINE VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PORCINE VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. INACTIVATED VACCINES
7.3.1. Overview
7.3.2. Inactivated Vaccines Market Forecast and Analysis
7.4. LIVE ATTENUATED VACCINES
7.4.1. Overview
7.4.2. Live Attenuated Vaccines Market Forecast and Analysis
7.5. TOXOID VACCINES
7.5.1. Overview
7.5.2. Toxoid Vaccines Market Forecast and Analysis
7.6. RECOMBINANT VACCINES
7.6.1. Overview
7.6.2. Recombinant Vaccines Market Forecast and Analysis
7.7. CONJUGATE VACCINES
7.7.1. Overview
7.7.2. Conjugate Vaccines Market Forecast and Analysis
7.8. DNA VACCINES
7.8.1. Overview
7.8.2. DNA Vaccines Market Forecast and Analysis
8. PORCINE VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. DIARRHEA
8.3.1. Overview
8.3.2. Diarrhea Market Forecast and Analysis
8.4. SWINE INFLUENZA
8.4.1. Overview
8.4.2. Swine Influenza Market Forecast and Analysis
8.5. ARTHRITIS
8.5.1. Overview
8.5.2. Arthritis Market Forecast and Analysis
8.6. BORDATELLA RHINITIS
8.6.1. Overview
8.6.2. Bordatella Rhinitis Market Forecast and Analysis
8.7. PORCINE REPRODUCTIVE AND RESPIRATORY VIRUS (PRRSV)
8.7.1. Overview
8.7.2. Porcine Reproductive and Respiratory Virus (PRRSV) Market Forecast and Analysis
8.8. PORCINE CIRCOVIRUS ASSOCIATED DISEASE (PCVAD)
8.8.1. Overview
8.8.2. Porcine Circovirus Associated Disease (PCVAD) Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. PORCINE VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. VETERINARY HOSPITALS
9.3.1. Overview
9.3.2. Veterinary Hospitals Market Forecast and Analysis
9.4. HOG/PIG PRODUCTION FARM
9.4.1. Overview
9.4.2. Hog/Pig Production Farm Market Forecast and Analysis
10. PORCINE VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Porcine Vaccine Market Overview
10.1.2 North America Porcine Vaccine Market Forecasts and Analysis
10.1.3 North America Porcine Vaccine Market Forecasts and Analysis - By Technology
10.1.4 North America Porcine Vaccine Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Porcine Vaccine Market Forecasts and Analysis - By End User
10.1.6 North America Porcine Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Porcine Vaccine Market
10.1.6.1.1 United States Porcine Vaccine Market by Technology
10.1.6.1.2 United States Porcine Vaccine Market by Disease Indication
10.1.6.1.3 United States Porcine Vaccine Market by End User
10.1.6.2 Canada Porcine Vaccine Market
10.1.6.2.1 Canada Porcine Vaccine Market by Technology
10.1.6.2.2 Canada Porcine Vaccine Market by Disease Indication
10.1.6.2.3 Canada Porcine Vaccine Market by End User
10.1.6.3 Mexico Porcine Vaccine Market
10.1.6.3.1 Mexico Porcine Vaccine Market by Technology
10.1.6.3.2 Mexico Porcine Vaccine Market by Disease Indication
10.1.6.3.3 Mexico Porcine Vaccine Market by End User
10.2. EUROPE
10.2.1 Europe Porcine Vaccine Market Overview
10.2.2 Europe Porcine Vaccine Market Forecasts and Analysis
10.2.3 Europe Porcine Vaccine Market Forecasts and Analysis - By Technology
10.2.4 Europe Porcine Vaccine Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Porcine Vaccine Market Forecasts and Analysis - By End User
10.2.6 Europe Porcine Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Porcine Vaccine Market
10.2.6.1.1 Germany Porcine Vaccine Market by Technology
10.2.6.1.2 Germany Porcine Vaccine Market by Disease Indication
10.2.6.1.3 Germany Porcine Vaccine Market by End User
10.2.6.2 France Porcine Vaccine Market
10.2.6.2.1 France Porcine Vaccine Market by Technology
10.2.6.2.2 France Porcine Vaccine Market by Disease Indication
10.2.6.2.3 France Porcine Vaccine Market by End User
10.2.6.3 Italy Porcine Vaccine Market
10.2.6.3.1 Italy Porcine Vaccine Market by Technology
10.2.6.3.2 Italy Porcine Vaccine Market by Disease Indication
10.2.6.3.3 Italy Porcine Vaccine Market by End User
10.2.6.4 Spain Porcine Vaccine Market
10.2.6.4.1 Spain Porcine Vaccine Market by Technology
10.2.6.4.2 Spain Porcine Vaccine Market by Disease Indication
10.2.6.4.3 Spain Porcine Vaccine Market by End User
10.2.6.5 United Kingdom Porcine Vaccine Market
10.2.6.5.1 United Kingdom Porcine Vaccine Market by Technology
10.2.6.5.2 United Kingdom Porcine Vaccine Market by Disease Indication
10.2.6.5.3 United Kingdom Porcine Vaccine Market by End User
10.2.6.6 Rest of Europe Porcine Vaccine Market
10.2.6.6.1 Rest of Europe Porcine Vaccine Market by Technology
10.2.6.6.2 Rest of Europe Porcine Vaccine Market by Disease Indication
10.2.6.6.3 Rest of Europe Porcine Vaccine Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Porcine Vaccine Market Overview
10.3.2 Asia-Pacific Porcine Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Porcine Vaccine Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Porcine Vaccine Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Porcine Vaccine Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Porcine Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Porcine Vaccine Market
10.3.6.1.1 Australia Porcine Vaccine Market by Technology
10.3.6.1.2 Australia Porcine Vaccine Market by Disease Indication
10.3.6.1.3 Australia Porcine Vaccine Market by End User
10.3.6.2 China Porcine Vaccine Market
10.3.6.2.1 China Porcine Vaccine Market by Technology
10.3.6.2.2 China Porcine Vaccine Market by Disease Indication
10.3.6.2.3 China Porcine Vaccine Market by End User
10.3.6.3 India Porcine Vaccine Market
10.3.6.3.1 India Porcine Vaccine Market by Technology
10.3.6.3.2 India Porcine Vaccine Market by Disease Indication
10.3.6.3.3 India Porcine Vaccine Market by End User
10.3.6.4 Japan Porcine Vaccine Market
10.3.6.4.1 Japan Porcine Vaccine Market by Technology
10.3.6.4.2 Japan Porcine Vaccine Market by Disease Indication
10.3.6.4.3 Japan Porcine Vaccine Market by End User
10.3.6.5 South Korea Porcine Vaccine Market
10.3.6.5.1 South Korea Porcine Vaccine Market by Technology
10.3.6.5.2 South Korea Porcine Vaccine Market by Disease Indication
10.3.6.5.3 South Korea Porcine Vaccine Market by End User
10.3.6.6 Rest of Asia-Pacific Porcine Vaccine Market
10.3.6.6.1 Rest of Asia-Pacific Porcine Vaccine Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Porcine Vaccine Market by Disease Indication
10.3.6.6.3 Rest of Asia-Pacific Porcine Vaccine Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Porcine Vaccine Market Overview
10.4.2 Middle East and Africa Porcine Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Porcine Vaccine Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Porcine Vaccine Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Porcine Vaccine Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Porcine Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Porcine Vaccine Market
10.4.6.1.1 South Africa Porcine Vaccine Market by Technology
10.4.6.1.2 South Africa Porcine Vaccine Market by Disease Indication
10.4.6.1.3 South Africa Porcine Vaccine Market by End User
10.4.6.2 Saudi Arabia Porcine Vaccine Market
10.4.6.2.1 Saudi Arabia Porcine Vaccine Market by Technology
10.4.6.2.2 Saudi Arabia Porcine Vaccine Market by Disease Indication
10.4.6.2.3 Saudi Arabia Porcine Vaccine Market by End User
10.4.6.3 U.A.E Porcine Vaccine Market
10.4.6.3.1 U.A.E Porcine Vaccine Market by Technology
10.4.6.3.2 U.A.E Porcine Vaccine Market by Disease Indication
10.4.6.3.3 U.A.E Porcine Vaccine Market by End User
10.4.6.4 Rest of Middle East and Africa Porcine Vaccine Market
10.4.6.4.1 Rest of Middle East and Africa Porcine Vaccine Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Porcine Vaccine Market by Disease Indication
10.4.6.4.3 Rest of Middle East and Africa Porcine Vaccine Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Porcine Vaccine Market Overview
10.5.2 South and Central America Porcine Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Porcine Vaccine Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Porcine Vaccine Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Porcine Vaccine Market Forecasts and Analysis - By End User
10.5.6 South and Central America Porcine Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Porcine Vaccine Market
10.5.6.1.1 Brazil Porcine Vaccine Market by Technology
10.5.6.1.2 Brazil Porcine Vaccine Market by Disease Indication
10.5.6.1.3 Brazil Porcine Vaccine Market by End User
10.5.6.2 Argentina Porcine Vaccine Market
10.5.6.2.1 Argentina Porcine Vaccine Market by Technology
10.5.6.2.2 Argentina Porcine Vaccine Market by Disease Indication
10.5.6.2.3 Argentina Porcine Vaccine Market by End User
10.5.6.3 Rest of South and Central America Porcine Vaccine Market
10.5.6.3.1 Rest of South and Central America Porcine Vaccine Market by Technology
10.5.6.3.2 Rest of South and Central America Porcine Vaccine Market by Disease Indication
10.5.6.3.3 Rest of South and Central America Porcine Vaccine Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PORCINE VACCINE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PORCINE VACCINE MARKET, KEY COMPANY PROFILES
13.1. BAYER AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIMEDA ANIMAL HEALTH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOEHRINGER INGELHEIM GMBH
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CEVA SANTE ANIMALE
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ELI LILLY AND COMPANY
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERCK AND CO., INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SANOFI S.A
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. VETOQUINOL
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ZOETIS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. HIPRA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. Bimeda Animal Health
3. Boehringer Ingelheim GmbH
4. Ceva Sante Animale
5. Eli Lilly and Company
6. Merck and Co., Inc.
7. Sanofi S.A
8. Vetoquinol
9. Zoetis, Inc.
10. Hipra
11. Elanco
12. Formosa Biomedical Inc.
13. Shoken Pharmaceutical Co., Ltd
14. MSD Animal Health
TIPRE00021695
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount